Role of Vitamins in Cardiovascular Health: Know Your Facts - Part 1

Antonis   A.   Manolis; Theodora      Manolis; Helen      Melita; Antonis   S.   Manolis
doi:10.2174/1570161121666230912155548
Abstract

Cardiovascular (CV) disease (CVD) is a major cause of morbidity and mortality world-wide, thus it is important to adopt preventive interventions. Observational data demonstrating CV benefits of vitamin supplements, advanced by self-proclaimed experts have resulted in ~50% of Americans reporting the use of multivitamins for health promotion; this practice has led to a multi-billion-dollar business of the multivitamin-industry. However, the data on the extensive use of multivitamins show no consistent benefit for CVD prevention or all-cause mortality, while the use of certain vitamins might prove harmful. Thus, the focus of this two-part review is on the attributes or concerns about specific vitamins on CVD.
In Part 1, the CV effects of specific vitamins are discussed, indicating the need for further supportive evidence of potential benefits. Vitamin A preserves CV homeostasis as it participates in many biologic functions, including atherosclerosis. However, supplementation could potentially be harmful. Betacarotene, a pro-vitamin A, conveys pro-oxidant actions that may mitigate any other benefits. Folic acid alone and certain B-vitamins (e.g., B1/B2/B6/B12) may reduce CVD, heart failure, and/or stroke, while niacin might increase mortality. Vitamin C has antioxidant and cardioprotective effects. Vitamin D may confer CV protection, but all the data are not in agreement. Combined vitamin E and C have antiatherogenic effects but clinical evidence is inconsistent. Vitamin K seems neutral. Thus, there are individual vitamin actions with favorable CV impact (certain B-vitamins and vitamins C and D), but other vitamins (β-carotene, niacin) may potentially have deleterious effects, which also holds true for high doses of fat-soluble vitamins (A/D/E/K).
Keywords: Vitamins, cardiovascular disease, atherosclerosis, coronary artery disease, hypertension, heart failure, stroke, endothelial dysfunction.
« Previous Next »
Graphical Abstract

[1]
 Caulfield T. The multivitamin industry rakes in billions of dollars. But science says we're not getting healthier. 2018. Available from: https://www.nbcnews.com/think/opinion/multivitamin-industry-rakes-billions-dollars-science-says-we-re-not-ncna898191

[2]
 PrecedenceResearch. Vitamin Supplements Market. 2022. Available from: https://www.precedenceresearch.com/vitamin-supplements-market

[3]
White ND. Messaging and multivitamin use: Rethinking the “It Can’t Hurt” philosophy. Am J Lifestyle Med  2019; 13(3): 243-5.
 [http://dx.doi.org/10.1177/1559827619826572] [PMID: 31105485]

[4]
Manolis AA, Manolis TA, Melita H, Manolis AS. Features of a balanced healthy diet with cardiovascular and other benefits. Curr Vasc Pharmacol  2023; 21(3): 163-84.
 [http://dx.doi.org/10.2174/1570161121666230327135916] [PMID: 36974413]

[5]
Simsek B, Selte A, Egeli BH, Çakatay U. Effects of vitamin supplements on clinical cardiovascular outcomes: Time to move on! – A comprehensive review. Clin Nutr ESPEN  2021; 42: 1-14.
 [http://dx.doi.org/10.1016/j.clnesp.2021.02.014] [PMID: 33745562]

[6]
Sesso HD, Rist PM, Aragaki AK, et al. Multivitamins in the prevention of cancer and cardiovascular disease: The COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial. Am J Clin Nutr  2022; 115(6): 1501-10.
 [http://dx.doi.org/10.1093/ajcn/nqac056] [PMID: 35294969]

[7]
Sunkara A, Raizner A. Supplemental vitamins and minerals for cardiovascular disease prevention and treatment. Methodist DeBakey Cardiovasc J  2019; 15(3): 179-84.
 [http://dx.doi.org/10.14797/mdcj-15-3-179] [PMID: 31687096]

[8]
Honarbakhsh S, Schachter M. Vitamins and cardiovascular disease. Br J Nutr  2009; 101(8): 1113-31.
 [http://dx.doi.org/10.1017/S000711450809123X] [PMID: 18826726]

[9]
Jenkins DJA, Spence JD, Giovannucci EL, et al. Supplemental vitamins and minerals for CVD prevention and treatment. J Am Coll Cardiol  2018; 71(22): 2570-84.
 [http://dx.doi.org/10.1016/j.jacc.2018.04.020] [PMID: 29852980]

[10]
Ingles DP, Cruz Rodriguez JB, Garcia H. Supplemental vitamins and minerals for cardiovascular disease prevention and treatment. Curr Cardiol Rep  2020; 22(4): 22.
 [http://dx.doi.org/10.1007/s11886-020-1270-1] [PMID: 32067177]

[11]
Jenkins DJA, Spence JD, Giovannucci EL, et al. Supplemental vitamins and minerals for cardiovascular disease prevention and treatment. J Am Coll Cardiol  2021; 77(4): 423-36.
 [http://dx.doi.org/10.1016/j.jacc.2020.09.619] [PMID: 33509399]

[12]
Manolis AA, Manolis TA, Melita H, Manolis AS. Role of vitamins in cardiovascular health: Know your facts-Part II. Curr Vasc Pharmacol  2023; 21. in press

[13]
Shah AK, Dhalla NS. Effectiveness of some vitamins in the prevention of cardiovascular disease: A narrative review. Front Physiol  2021; 12: 729255.
 [http://dx.doi.org/10.3389/fphys.2021.729255] [PMID: 34690803]

[14]
Guéant JL, Guéant-Rodriguez RM, Oussalah A, Zuily S, Rosenberg I. Hyperhomocysteinemia in cardiovascular diseases: Revisiting observational studies and clinical trials. Thromb Haemost  2023; 123(3): 270-82.
 [http://dx.doi.org/10.1055/a-1952-1946] [PMID: 36170884]

[15]
Rodrigo R, Prieto JC, Aguayo R, et al. Joint cardioprotective effect of vitamin C and other antioxidants against reperfusion injury in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Molecules  2021; 26(18): 5702.
 [http://dx.doi.org/10.3390/molecules26185702] [PMID: 34577176]

[16]
Khan SA, Bhattacharjee S, Ghani MOA, Walden R, Chen QM. Vitamin C for cardiac protection during percutaneous coronary intervention: A systematic review of randomized controlled trials. Nutrients  2020; 12(8): 2199.
 [http://dx.doi.org/10.3390/nu12082199] [PMID: 32718091]

[17]
Dziedzic EA, Gąsior JS, Tuzimek A, Dąbrowski M, Jankowski P. The association between serum vitamin D concentration and new in-flammatory biomarkers—systemic inflammatory index (SII) and systemic inflammatory response (SIRI)—in patients with ischemic heart disease. Nutrients  2022; 14(19): 4212.
 [http://dx.doi.org/10.3390/nu14194212] [PMID: 36235864]

[18]
Manolis AS, Manolis TA, Melita H. Atherosclerosis: An athero-thrombo-inflammatory disease. Hosp Chron  2012; 7(4): 195-201.

[19]
Kose M, Senkal N, Tukek T, et al. Severe vitamin D deficiency is associated with endothelial inflammation in healthy individuals even in the absence of subclinical atherosclerosis. Eur Rev Med Pharmacol Sci  2022; 26(19): 7046-52.
 [PMID: 36263552]

[20]
Zhou Y, Jiang M, Sun JY, et al. The association between vitamin D levels and the 10-year risk of atherosclerotic cardiovascular disease. J Cardiovasc Nurs 2022.
 [http://dx.doi.org/10.1097/JCN.0000000000000943] [PMID: 36178328]

[21]
Uguz B, Oztas S, Zengin I, et al. Relationship between vitamin D deficiency and thrombus load in patients with ST-elevation myocardial infarction. Eur Rev Med Pharmacol Sci  2022; 26(19): 7015-23.
 [PMID: 36263549]

[22]
Polytarchou K, Dimitroglou Y, Varvarousis D, et al. Methylmalonic acid and vitamin B12 in patients with heart failure. Hellenic J Cardiol  2020; 61(5): 330-7.
 [http://dx.doi.org/10.1016/j.hjc.2019.10.010] [PMID: 31740360]

[23]
DiNicolantonio JJ, Liu J, O’Keefe JH. Thiamine and cardiovascular disease: A literature review. Prog Cardiovasc Dis  2018; 61(1): 27-32.
 [http://dx.doi.org/10.1016/j.pcad.2018.01.009] [PMID: 29360523]

[24]
Abe K, Kibe R, David K, Reddy V, Allard B, Fakaosita M. Reversible right-sided heart failure and pulmonary hypertension caused by scurvy in a 7-year-old boy with autism spectrum disorder and a review of the literature. Paediatr Int Child Health  2021; 1-5: 1-5.
 [http://dx.doi.org/10.1080/20469047.2021.1901406] [PMID: 34033530]

[25]
Wu JR, Song EK, Moser DK, Lennie TA. Dietary vitamin C deficiency is associated with health-related quality of life and cardiac event-free survival in adults with heart failure. J Cardiovasc Nurs  2019; 34(1): 29-35.
 [http://dx.doi.org/10.1097/JCN.0000000000000521] [PMID: 30211815]

[26]
Shinke T, Shite J, Takaoka H, et al. Vitamin C restores the contractile response to dobutamine and improves myocardial efficiency in patients with heart failure after anterior myocardial infarction. Am Heart J  2007; 154(4): 645.e1-8.
 [http://dx.doi.org/10.1016/j.ahj.2007.07.005] [PMID: 17892985]

[27]
Viswanatha Swamy AHM, Koti BC, Ronad PM, Wangikar U, Thippeswamy AHM, Manjula DV. Cardioprotective effect of ascorbic acid on doxorubicin-induced myocardial toxicity in rats. Indian J Pharmacol  2011; 43(5): 507-11.
 [http://dx.doi.org/10.4103/0253-7613.84952] [PMID: 22021990]

[28]
Song EK, Kang SM, Vitamin C. Vitamin C deficiency, high-sensitivity creactive protein, and cardiac event-free survival in patients with heart failure. J Cardiovasc Nurs  2018; 33(1): 6-12.
 [http://dx.doi.org/10.1097/JCN.0000000000000389] [PMID: 27984333]

[29]
Hemilä H, Chalker E, de Man AME, Vitamin C. Vitamin C may improve left ventricular ejection fraction: A meta-analysis. Front Cardiovasc Med  2022; 9: 789729.
 [http://dx.doi.org/10.3389/fcvm.2022.789729] [PMID: 35282368]

[30]
Hazique M, Khan KI, Ramesh P, et al. A study of vitamin D and its correlation with severity and complication of congestive heart failure: A systematic review. Cureus  2022; 14(9): e28873.
 [http://dx.doi.org/10.7759/cureus.28873] [PMID: 36225454]

[31]
Zhang Y, Liu M, Zhou C, et al. Inverse association between dietary vitamin A intake and new-onset hypertension. Clin Nutr  2021; 40(5): 2868-75.
 [http://dx.doi.org/10.1016/j.clnu.2021.04.004] [PMID: 33940400]

[32]
Lv J, Wang Y, Zhao Y, et al. Plasma levels of vitamin A in early pregnancy and correlationship with hypertensive disorder. Comput Math Methods Med  2022; 2022: 1-5.
 [http://dx.doi.org/10.1155/2022/3081720] [PMID: 35633926]

[33]
Li H, He P, Lin T, et al. Association between plasma retinol levels and the risk of all‐cause mortality in general hypertensive patients: A nested case‐control study. J Clin Hypertens  2020; 22(5): 906-13.
 [http://dx.doi.org/10.1111/jch.13866] [PMID: 32352642]

[34]
Ran L, Zhao W, Tan X, et al. Association between serum vitamin C and the blood pressure: A systematic review and meta-analysis of observational studies. Cardiovasc Ther  2020; 2020: 1-11.
 [http://dx.doi.org/10.1155/2020/4940673] [PMID: 32426036]

[35]
Wu Z, Wu Y, Rao J, et al. Associations among vitamin D, tobacco smoke, and hypertension: A cross-sectional study of the NHANES 2001–2016. Hypertens Res  2022; 45(12): 1986-96.
 [http://dx.doi.org/10.1038/s41440-022-01023-x] [PMID: 36202982]

[36]
Zhang Y, Yang S, Wu Q, et al. Dietary vitamin E intake and new-onset hypertension. Hypertens Res  2023; 46(5): 1267-75.
 [http://dx.doi.org/10.1038/s41440-022-01163-0] [PMID: 36609495]

[37]
Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin d, diabetes, and ethnicity in the third national health and nutrition examination survey. Diabetes Care  2004; 27(12): 2813-8.
 [http://dx.doi.org/10.2337/diacare.27.12.2813] [PMID: 15562190]

[38]
Alrefai AA, Elsalamony E, Fatani SH, Kasemy ZA, Fatani A, Mohamed Kamel HF. The association between vitamin D hypovitaminosis and cardiovascular disease risk in Saudi diabetic patients type II. Biochem Res Int  2022; 2022: 1-8.
 [http://dx.doi.org/10.1155/2022/6097864] [PMID: 36193546]

[39]
Pittas AG, Kawahara T, Jorde R, et al. Vitamin D and risk for type 2 diabetes in people with prediabetes. Ann Intern Med  2023; 176(3): 355-63.
 [http://dx.doi.org/10.7326/M22-3018] [PMID: 36745886]

[40]
Wu S, Feng P, Li W, et al. Dietary folate, vitamin B6, and vitamin B12 and risk of cardiovascular diseases among individuals with type 2 diabetes: A case-control study. Ann Nutr Metab  2023; 79(1): 5-15.
 [http://dx.doi.org/10.1159/000527529] [PMID: 36228591]

[41]
Fung GJ, Steffen LM, Zhou X, et al. Vitamin D intake is inversely related to risk of developing metabolic syndrome in African American and white men and women over 20 y: The Coronary Artery Risk Development in Young Adults study. Am J Clin Nutr  2012; 96(1): 24-9.
 [http://dx.doi.org/10.3945/ajcn.112.036863] [PMID: 22648727]

[42]
Zhu J, Chen C, Lu L, Shikany JM, D’Alton ME, Kahe K. Folate, vitamin B 6, and vitamin B 12 status in association with metabolic syndrome incidence. JAMA Netw Open  2023; 6(1): e2250621.
 [http://dx.doi.org/10.1001/jamanetworkopen.2022.50621] [PMID: 36630134]

[43]
Shi J, Fang H, Cheng X, et al. Nutrient patterns and its association and metabolic syndrome among chinese children and adolescents aged 7–17. Nutrients  2022; 15(1): 117.
 [http://dx.doi.org/10.3390/nu15010117] [PMID: 36615775]

[44]
Shivkar RR, Gawade GC, Padwal MK, Diwan AG, Mahajan SA, Kadam CY. Association of MTHFR C677T (rs1801133) and A1298C (rs1801131) polymorphisms with serum homocysteine, folate and vitamin B12 in patients with young coronary artery disease. Indian J Clin Biochem  2022; 37(2): 224-31.
 [http://dx.doi.org/10.1007/s12291-021-00982-1] [PMID: 35463099]

[45]
Hoţoleanu C, Porojan-Iuga M, Rusu ML, Andercou A. Hyperhomocysteinemia: Clinical and therapeutical involvement in venous throm-bosis. Rom J Intern Med  2007; 45(2): 159-64.
 [PMID: 18333369]

[46]
Mohan IV, Jagroop IA, Mikhailidis DP, Stansby GP. Homocysteine activates platelets in vitro. Clin Appl Thromb Hemost  2008; 14(1): 8-18.
 [http://dx.doi.org/10.1177/1076029607308390] [PMID: 18160593]

[47]
Gonzalez A, Smith GH, Gambello MJ, Sokolová J, Kožich V, Li H. Elevated homocysteine levels: What inborn errors of metabolism might we be missing? Am J Med Genet A  2023; 191(1): 130-4.
 [http://dx.doi.org/10.1002/ajmg.a.63001] [PMID: 36271828]

[48]
Zhang T, Liang Z, Lin T, et al. Cost-effectiveness of folic acid therapy for primary prevention of stroke in patients with hypertension. BMC Med  2022; 20(1): 407.
 [http://dx.doi.org/10.1186/s12916-022-02601-z] [PMID: 36280851]

[49]
Yuan S, Chen J, Dan L, et al. Homocysteine, folate, and nonalcoholic fatty liver disease: A systematic review with meta-analysis and Mendelian randomization investigation. Am J Clin Nutr  2022; 116(6): 1595-609.
 [http://dx.doi.org/10.1093/ajcn/nqac285] [PMID: 36205540]

[50]
Qin X, Spence JD, Li J, et al. Interaction of serum vitamin B 12 and folate with MTHFR genotypes on risk of ischemic stroke. Neurology  2020; 94(11): e1126-36.
 [http://dx.doi.org/10.1212/WNL.0000000000008932] [PMID: 31932513]

[51]
Yang HT, Lee M, Hong KS, Ovbiagele B, Saver JL. Efficacy of folic acid supplementation in cardiovascular disease prevention: An updated meta-analysis of randomized controlled trials. Eur J Intern Med  2012; 23(8): 745-54.
 [http://dx.doi.org/10.1016/j.ejim.2012.07.004] [PMID: 22884409]

[52]
Ji Y, Tan S, Xu Y, et al. Vitamin B supplementation, homocysteine levels, and the risk of cerebrovascular disease: A meta-analysis. Neurology  2013; 81(15): 1298-307.
 [http://dx.doi.org/10.1212/WNL.0b013e3182a823cc] [PMID: 24049135]

[53]
Zhao M, Wu G, Li Y, et al. Meta-analysis of folic acid efficacy trials in stroke prevention. Neurology  2017; 88(19): 1830-8.
 [http://dx.doi.org/10.1212/WNL.0000000000003909] [PMID: 28404799]

[54]
Vergatti A, Abate V, Zarrella AF, et al. 25-Hydroxy-vitamin D and risk of recurrent stroke: A dose response meta-analysis. Nutrients  2023; 15(3): 512.
 [http://dx.doi.org/10.3390/nu15030512] [PMID: 36771220]

[55]
Lees JS, Chapman FA, Witham MD, Jardine AG, Mark PB. Vitamin K status, supplementation and vascular disease: A systematic review and meta-analysis. Heart  2019; 105(12): 938-45.
 [PMID: 30514729]

[56]
Kosciuszek ND, Kalta D, Singh M, Savinova OV. Vitamin K antagonists and cardiovascular calcification: A systematic review and meta-analysis. Front Cardiovasc Med  2022; 9: 938567.
 [http://dx.doi.org/10.3389/fcvm.2022.938567] [PMID: 36061545]

[57]
Mohan A, Kumar R, Kumar V, Yadav M. Homocysteine, vitamin B12 and folate level: Possible risk factors in the progression of chronic heart and kidney disorders. Curr Cardiol Rev  2023; 19(4): e090223213539.
 [http://dx.doi.org/10.2174/1573403X19666230209111854] [PMID: 36757031]

[58]
Gholipur-Shahraki T, Badri S, Vahdat S, Seirafian S, Pourfarzam M, Ataei S. Homocysteine-lowering interventions in chronic kidney disease. J Res Pharm Pract  2021; 10(3): 114-24.
 [http://dx.doi.org/10.4103/jrpp.jrpp_75_21] [PMID: 35198504]

[59]
Qin X, Huo Y, Xie D, Hou F, Xu X, Wang X. Homocysteine-lowering therapy with folic acid is effective in cardiovascular disease prevention in patients with kidney disease: A meta-analysis of randomized controlled trials. Clin Nutr  2013; 32(5): 722-7.
 [http://dx.doi.org/10.1016/j.clnu.2012.12.009] [PMID: 23313356]

[60]
Capelli I, Cianciolo G, Gasperoni L, et al. Folic acid and vitamin B12 Administration in CKD, why not? Nutrients  2019; 11(2): 383.
 [http://dx.doi.org/10.3390/nu11020383] [PMID: 30781775]

[61]
Angelini A, Cappuccilli ML, Magnoni G, et al. The link between homocysteine, folic acid and vitamin B12 in chronic kidney disease. G Ital Nefrol  2021; 38(4): 2021-vol4.
 [PMID: 34469084]

[62]
Xiao W, Ye P, Wang F, Cao R, Bai Y, Wang X. Plasma homocysteine is a predictive factor for accelerated renal function decline and chronic kidney disease in a community-dwelling population. Kidney Blood Press Res  2021; 46(5): 541-9.
 [http://dx.doi.org/10.1159/000514360] [PMID: 34365457]

[63]
Shih YL, Shih CC, Chen JY. Elevated homocysteine level as an indicator for chronic kidney disease in community-dwelling middle-aged and elderly populations in Taiwan: A community-based cross-sectional study. Front Med  2022; 9: 964101.
 [http://dx.doi.org/10.3389/fmed.2022.964101] [PMID: 36004372]

[64]
Xiong Y, Zhang Y, Zhang F, et al. Genetic evidence supporting the causal role of homocysteine in chronic kidney disease: A mendelian randomization study. Front Nutr  2022; 9: 843534.
 [http://dx.doi.org/10.3389/fnut.2022.843534] [PMID: 35495913]

[65]
Park S, Lee S, Kim Y, et al. Causal Effects of homocysteine, folate, and cobalamin on kidney function: A mendelian randomization study. Nutrients  2021; 13(3): 906.
 [http://dx.doi.org/10.3390/nu13030906] [PMID: 33799553]

[66]
Li Y, Spence JD, Wang X, Huo Y, Xu X, Qin X. Effect of vitamin B12 levels on the association between folic acid treatment and CKD Progression: A post hoc analysis of a folic acid interventional trial. Am J Kidney Dis  2020; 75(3): 325-32.
 [http://dx.doi.org/10.1053/j.ajkd.2019.07.020] [PMID: 31629573]

[67]
Reno-Bernstein CM, Oxspring M, Bayles J, Huang EY, Holiday I, Fisher SJ. Vitamin E treatment in insulin-deficient diabetic rats reduces cardiac arrhythmias and mortality during severe hypoglycemia. Am J Physiol Endocrinol Metab  2022; 323(5): E428-34.
 [http://dx.doi.org/10.1152/ajpendo.00188.2022] [PMID: 36198111]

[68]
Hemilä H, Suonsyrjä T. Vitamin C for preventing atrial fibrillation in high risk patients: A systematic review and meta-analysis. BMC Cardiovasc Disord  2017; 17(1): 49.
 [http://dx.doi.org/10.1186/s12872-017-0478-5] [PMID: 28143406]

[69]
Talasaz AH, Salehiomran A, Heidary Z, et al. The effects of vitamin D supplementation on postoperative atrial fibrillation after coronary artery bypass grafting in patients with vitamin D deficiency. J Card Surg  2022; 37(7): 2219-24.
 [http://dx.doi.org/10.1111/jocs.16550] [PMID: 35470909]

[70]
Olsen T, Blomhoff R. Retinol, retinoic acid, and retinol-binding protein 4 are differentially associated with cardiovascular disease, type 2 diabetes, and obesity: An overview of human studies. Adv Nutr  2020; 11(3): 644-66.
 [http://dx.doi.org/10.1093/advances/nmz131] [PMID: 31868199]

[71]
Yadav AS, Isoherranen N, Rubinow KB. Vitamin A homeostasis and cardiometabolic disease in humans: Lost in translation? J Mol Endocrinol  2022; 69(3): R95-R108.
 [http://dx.doi.org/10.1530/JME-22-0078] [PMID: 35900842]

[72]
Deng Q, Chen J. Potential therapeutic effect of all-trans retinoic acid on atherosclerosis. Biomolecules  2022; 12(7): 869.
 [http://dx.doi.org/10.3390/biom12070869] [PMID: 35883425]

[73]
Schiborn C, Weber D, Grune T, et al. Retinol and retinol binding protein 4 levels and cardiometabolic disease risk. Circ Res  2022; 131(7): 637-49.
 [http://dx.doi.org/10.1161/CIRCRESAHA.122.321295] [PMID: 36017698]

[74]
Yang J, Zhang Y, Na X, Zhao A. β-Carotene supplementation and risk of cardiovascular disease: A systematic review and meta-analysis of randomized controlled trials. Nutrients  2022; 14(6): 1284.
 [http://dx.doi.org/10.3390/nu14061284] [PMID: 35334942]

[75]
Peterson CT, Rodionov DA, Osterman AL, Peterson SN. B vitamins and their role in immune regulation and cancer. Nutrients  2020; 12(11): 3380.
 [http://dx.doi.org/10.3390/nu12113380] [PMID: 33158037]

[76]
Zhang B, Dong H, Xu Y, Xu D, Sun H, Han L. Associations of dietary folate, vitamin B6 and B12 intake with cardiovascular outcomes in 115664 participants: A large UK population-based cohort. Eur J Clin Nutr  2023; 77(3): 299-307.
 [http://dx.doi.org/10.1038/s41430-022-01206-2] [PMID: 36100703]

[77]
Yuan S, Mason AM, Carter P, Burgess S, Larsson SC. Homocysteine, B vitamins, and cardiovascular disease: A Mendelian randomization study. BMC Med  2021; 19(1): 97.
 [http://dx.doi.org/10.1186/s12916-021-01977-8] [PMID: 33888102]

[78]
Darand M, Hassanizadeh S, Martami F, Shams S, Mirzaei M, Hosseinzadeh M. The association between B vitamins and the risk of COVID-19. Br J Nutr  2023; 130(1): 155-63.
 [http://dx.doi.org/10.1017/S0007114522003075] [PMID: 36348570]

[79]
Wan Z, Zheng J, Zhu Z, et al. Intermediate role of gut microbiota in vitamin B nutrition and its influences on human health. Front Nutr  2022; 9: 1031502.
 [http://dx.doi.org/10.3389/fnut.2022.1031502] [PMID: 36583209]

[80]
Barone M, D’Amico F, Brigidi P, Turroni S. Gut microbiome–micronutrient interaction: The key to controlling the bioavailability of minerals and vitamins? Biofactors  2022; 48(2): 307-14.
 [http://dx.doi.org/10.1002/biof.1835] [PMID: 35294077]

[81]
Rohun J, Dorniak K, Młodziński K, et al. Vitamin B1 deficiency and perimyocarditis fulminans: A case study of shoshin syndrome in a woman following an unbalanced dietary pattern followed by a literature review. Life  2023; 13(1): 205.
 [http://dx.doi.org/10.3390/life13010205] [PMID: 36676154]

[82]
Candrasatria RM, Adiarto S, Sukmawan R. Methylenetetrahydrofolate reductase C677T gene polymorphism as a risk factor for hypertension in a rural population. Int J Hypertens  2020; 2020: 1-6.
 [http://dx.doi.org/10.1155/2020/4267246] [PMID: 32411440]

[83]
Kang SS, Zhou J, Wong PW, Kowalisyn J, Strokosch G. Intermediate homocysteinemia: A thermolabile variant of methylenetetrahydro-folate reductase. Am J Hum Genet  1988; 43(4): 414-21.
 [PMID: 3177384]

[84]
Antoniades C, Shirodaria C, Leeson P, et al. MTHFR 677 C>T Polymorphism reveals functional importance for 5-methyltetrahydrofolate, not homocysteine, in regulation of vascular redox state and endothelial function in human atherosclerosis. Circulation  2009; 119(18): 2507-15.
 [http://dx.doi.org/10.1161/CIRCULATIONAHA.108.808675] [PMID: 19398669]

[85]
Niu W-Q, You Y-G, Qi Y. Strong association of methylenetetrahydrofolate reductase gene C677T polymorphism with hypertension and hypertension-in-pregnancy in Chinese: A meta-analysis. J Hum Hypertens  2012; 26(4): 259-67.
 [http://dx.doi.org/10.1038/jhh.2011.11] [PMID: 21346782]

[86]
Qian X, Lu Z, Tan M, Liu H, Lu D. A meta-analysis of association between C677T polymorphism in the methylenetetrahydrofolate reductase gene and hypertension. Eur J Hum Genet  2007; 15(12): 1239-45.
 [http://dx.doi.org/10.1038/sj.ejhg.5201914] [PMID: 17726486]

[87]
Wu YL, Hu CY, Lu SS, et al. Association between methylenetetrahydrofolate reductase (MTHFR) C677T/A1298C polymorphisms and essential hypertension: A systematic review and meta-analysis. Metabolism  2014; 63(12): 1503-11.
 [http://dx.doi.org/10.1016/j.metabol.2014.10.001] [PMID: 25458833]

[88]
Yang B, Fan S, Zhi X, et al. Associations of MTHFR gene polymorphisms with hypertension and hypertension in pregnancy: A meta-analysis from 114 studies with 15411 cases and 21970 controls. PLoS One  2014; 9(2): e87497.
 [http://dx.doi.org/10.1371/journal.pone.0087497] [PMID: 24505291]

[89]
McNulty H, Dowey LRC, Strain JJ, et al. Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C->T polymorphism. Circulation  2006; 113(1): 74-80.
 [http://dx.doi.org/10.1161/CIRCULATIONAHA.105.580332] [PMID: 16380544]

[90]
Horigan G, McNulty H, Ward M, Strain JJ, Purvis J, Scott JM. Riboflavin lowers blood pressure in cardiovascular disease patients homo-zygous for the 677C→T polymorphism in MTHFR. J Hypertens  2010; 28(3): 478-86.
 [http://dx.doi.org/10.1097/HJH.0b013e328334c126] [PMID: 19952781]

[91]
McNulty H, Strain JJ, Hughes CF, Ward M. Riboflavin, MTHFR genotype and blood pressure: A personalized approach to prevention and treatment of hypertension. Mol Aspects Med  2017; 53: 2-9.
 [http://dx.doi.org/10.1016/j.mam.2016.10.002] [PMID: 27720779]

[92]
Li M, Shi Z. Riboflavin intake inversely associated with cardiovascular-disease mortality and interacting with folate intake: Findings from the National Health and Nutrition Examination Survey (NHANES) 2005–2016. Nutrients  2022; 14(24): 5345.
 [http://dx.doi.org/10.3390/nu14245345] [PMID: 36558504]

[93]
Boden WE, Probstfield JL, Anderson T, et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med  2011; 365(24): 2255-67.
 [http://dx.doi.org/10.1056/NEJMoa1107579] [PMID: 22085343]

[94]
Ronsein GE, Vaisar T, Davidson WS, et al. Niacin increases atherogenic proteins in high-density lipoprotein of statin-treated subjects. Arterioscler Thromb Vasc Biol  2021; 41(8): 2330-41.
 [http://dx.doi.org/10.1161/ATVBAHA.121.316278] [PMID: 34134520]

[95]
Song S, Lee CJ, Oh J, Park S, Kang SM, Lee SH. Effect of niacin on carotid atherosclerosis in patients at low-density lipoprotein-cholesterol goal but high lipoprotein (a) Level: A 2-year follow-up study. J Lipid Atheroscler  2019; 8(1): 58-66.
 [http://dx.doi.org/10.12997/jla.2019.8.1.58] [PMID: 32821700]

[96]
Garg A, Sharma A, Krishnamoorthy P, et al. Role of Niacin in Current Clinical Practice: A Systematic Review. Am J Med  2017; 130(2): 173-87.
 [http://dx.doi.org/10.1016/j.amjmed.2016.07.038] [PMID: 27793642]

[97]
D’Andrea E, Hey SP, Ramirez CL, Kesselheim AS. Assessment of the role of niacin in managing cardiovascular disease outcomes. JAMA Netw Open  2019; 2(4): e192224.
 [http://dx.doi.org/10.1001/jamanetworkopen.2019.2224] [PMID: 30977858]

[98]
Sun P, Weng H, Fan F, et al. Association between plasma vitamin B5 and coronary heart disease: Results from a case-control study. Front Cardiovasc Med  2022; 9: 906232.
 [http://dx.doi.org/10.3389/fcvm.2022.906232] [PMID: 36312288]

[99]
Wojtczak L, Slyshenkov VS. Protection by pantothenic acid against apoptosis and cell damage by oxygen free radicals - The role of gluta-thione. Biofactors  2003; 17(1-4): 61-73.
 [http://dx.doi.org/10.1002/biof.5520170107] [PMID: 12897429]

[100]
Said HM. Intestinal absorption of water-soluble vitamins in health and disease. Biochem J  2011; 437(3): 357-72.
 [http://dx.doi.org/10.1042/BJ20110326] [PMID: 21749321]

[101]
Evans M, Rumberger J, Azumano I, Napolitano J, Citrolo D, Kamiya T. Pantethine, a derivative of vitamin B5, favorably alters total, LDL and non-HDL cholesterol in low to moderate cardiovascular risk subjects eligible for statin therapy: A triple-blinded placebo and diet-controlled investigation. Vasc Health Risk Manag  2014; 10: 89-100.
 [http://dx.doi.org/10.2147/VHRM.S57116] [PMID: 24600231]

[102]
Scott LN, Fiume M, Bergfeld WF, et al. Safety assessment of panthenol, pantothenic acid, and derivatives as used in cosmetics. Int J Toxicol  2022; 41(3_suppl)(Suppl.): 77-128.
 [http://dx.doi.org/10.1177/10915818221124809] [PMID: 36177798]

[103]
Tahiliani AG, Beinlich CJ. Pantothenic acid in health and disease. Vitam Horm  1991; 46: 165-228.
 [http://dx.doi.org/10.1016/S0083-6729(08)60684-6] [PMID: 1746161]

[104]
Gominak SC. Vitamin D deficiency changes the intestinal microbiome reducing B vitamin production in the gut. The resulting lack of pantothenic acid adversely affects the immune system, producing a “pro-inflammatory” state associated with atherosclerosis and autoimmuni-ty. Med Hypotheses  2016; 94: 103-7.
 [http://dx.doi.org/10.1016/j.mehy.2016.07.007] [PMID: 27515213]

[105]
Ostman-Smith I, Brown G, Johnson A, Land JM. Dilated cardiomyopathy due to type II X-linked 3-methylglutaconic aciduria: Successful treatment with pantothenic acid. Heart  1994; 72(4): 349-53.
 [http://dx.doi.org/10.1136/hrt.72.4.349] [PMID: 7833193]

[106]
Leonardi R, Jackowski S. Biosynthesis of pantothenic Acid and Coenzyme A. Ecosal Plus  2007; 2(2): ecosalplus.3.6.3.4.
 [http://dx.doi.org/10.1128/ecosalplus.3.6.3.4] [PMID: 26443589]

[107]
Carrara P, Matturri L, Galbussera M, Lovati MR, Franceschini G, Sirtori CR. Pantethine reduces plasma cholesterol and the severity of arterial lesions in experimental hypercholesterolemic rabbits. Atherosclerosis  1984; 53(3): 255-64.
 [http://dx.doi.org/10.1016/0021-9150(84)90126-6] [PMID: 6442152]

[108]
Houston MC, Fazio S, Chilton FH, et al. Nonpharmacologic treatment of dyslipidemia. Prog Cardiovasc Dis  2009; 52(2): 61-94.
 [http://dx.doi.org/10.1016/j.pcad.2009.02.002] [PMID: 19732602]

[109]
Pins JJ, Keenan JM. Dietary and nutraceutical options for managing the hypertriglyceridemic patient. Prog Cardiovasc Nurs  2006; 21(2): 89-93.
 [http://dx.doi.org/10.1111/j.0889-7204.2006.01776.x] [PMID: 16760691]

[110]
Houston M. The role of nutraceutical supplements in the treatment of dyslipidemia. J Clin Hypertens  2012; 14(2): 121-32.
 [http://dx.doi.org/10.1111/j.1751-7176.2011.00576.x] [PMID: 22277145]

[111]
Lopaschuk GD, Michalak M, Tsang H. Regulation of pantothenic acid transport in the heart. Involvement of a Na+-cotransport system. J Biol Chem  1987; 262(8): 3615-9.
 [http://dx.doi.org/10.1016/S0021-9258(18)61397-3] [PMID: 3818658]

[112]
Kalkan F, Parlakpinar H, Disli OM, et al. Protective and therapeutic effects of dexpanthenol on isoproterenol‐induced cardiac damage in rats. J Cell Biochem  2018; 119(9): 7479-89.
 [http://dx.doi.org/10.1002/jcb.27058] [PMID: 29775243]

[113]
Demirci B, Demir O, Dost T, Birincioglu M. Protective effect of vitamin B5 (dexpanthenol) on cardiovascular damage induced by streptozocin in rats. Bratisl Med J  2014; 115(4): 190-6.
 [http://dx.doi.org/10.4149/BLL_2014_040] [PMID: 24797592]

[114]
Zhou H, Zhang H, Ye R, et al. Pantothenate protects against obesity via brown adipose tissue activation. Am J Physiol Endocrinol Metab  2022; 323(1): E69-79.
 [http://dx.doi.org/10.1152/ajpendo.00293.2021] [PMID: 35575231]

[115]
Koyanagi T, Hareyama S, Kikuchi R, Kimura T. Effect of diet on the pantothenic acid content in serum and on the incidence of hypertension among villagers. Tohoku J Exp Med  1966; 88(1): 93-7.
 [http://dx.doi.org/10.1620/tjem.88.93] [PMID: 5920634]

[116]
Schwabedal PE, Pietrzik K, Wittkowski W. Pantothenic acid deficiency as a factor contributing to the development of hypertension. Cardiology  1985; 72(1): 187-9.
 [http://dx.doi.org/10.1159/000173972] [PMID: 4053129]

[117]
Hong Y, Zhou Z, Zhang N, et al. Association between plasma Vitamin B5 levels and all‐cause mortality: A nested case‐control study. J Clin Hypertens  2022; 24(7): 945-54.
 [http://dx.doi.org/10.1111/jch.14516] [PMID: 35699663]

[118]
Jeon J, Park K. Dietary vitamin B6 intake associated with a decreased risk of cardiovascular disease: A prospective cohort study. Nutrients  2019; 11(7): 1484.
 [http://dx.doi.org/10.3390/nu11071484] [PMID: 31261898]

[119]
Zhang N, Li Z, Wu Q, et al. Associations of Dietary Zinc–Vitamin B6 Ratio with All-Cause Mortality and Cardiovascular Disease Mortality Based on National Health and Nutrition Examination Survey 1999–2016. Nutrients  2023; 15(2): 420.
 [http://dx.doi.org/10.3390/nu15020420] [PMID: 36678291]

[120]
Dasgupta A. Immunoassay design and biotin interference. Adv Clin Chem  2022; 109: 165-83.
 [http://dx.doi.org/10.1016/bs.acc.2022.03.005] [PMID: 35953126]

[121]
Zempleni J, Kuroishi T. Biotin. Adv Nutr  2012; 3(2): 213-4.
 [http://dx.doi.org/10.3945/an.111.001305] [PMID: 22516729]

[122]
Belda E, Voland L, Tremaroli V, et al. Impairment of gut microbial biotin metabolism and host biotin status in severe obesity: Effect of biotin and prebiotic supplementation on improved metabolism. Gut  2022; 71(12): 2463-80.
 [http://dx.doi.org/10.1136/gutjnl-2021-325753] [PMID: 35017197]

[123]
Bowen R, Benavides R, Colón-Franco JM, et al. Best practices in mitigating the risk of biotin interference with laboratory testing. Clin Biochem  2019; 74: 1-11.
 [http://dx.doi.org/10.1016/j.clinbiochem.2019.08.012] [PMID: 31473202]

[124]
Schrapp A, Fraissinet F, Hervouet C, Girot H, Brunel V. Biotin and high-sensitivity cardiac troponin T assay. Biochem Med (Zagreb)  2018; 28(3): 030901.
 [http://dx.doi.org/10.11613/BM.2018.030901] [PMID: 30429682]

[125]
Avery G. Biotin interference in immunoassay: A review for the laboratory scientist. Ann Clin Biochem  2019; 56(4): 424-30.
 [http://dx.doi.org/10.1177/0004563219842231] [PMID: 31023057]

[126]
Espiritu AI, Remalante-Rayco PPM. High-dose biotin for multiple sclerosis: A systematic review and meta-analyses of randomized controlled trials. Mult Scler Relat Disord  2021; 55: 103159.
 [http://dx.doi.org/10.1016/j.msard.2021.103159] [PMID: 34332461]

[127]
Watanabe-Kamiyama M, Kamiyama S, Horiuchi K, et al. Antihypertensive effect of biotin in stroke-prone spontaneously hypertensive rats. Br J Nutr  2008; 99(4): 756-63.
 [http://dx.doi.org/10.1017/S0007114507841122] [PMID: 18179728]

[128]
Schutte AE, van Rooyen JM, Huisman HW, Kruger HS, Malan NT, De Ridder JH. Dietary risk markers that contribute to the aetiology of hypertension in black South African children: The THUSA BANA study. J Hum Hypertens  2003; 17(1): 29-35.
 [http://dx.doi.org/10.1038/sj.jhh.1001508] [PMID: 12571614]

[129]
Agrawal S, Agrawal A, Said HM. Biotin deficiency enhances the inflammatory response of human dendritic cells. Am J Physiol Cell Physiol  2016; 311(3): C386-91.
 [http://dx.doi.org/10.1152/ajpcell.00141.2016] [PMID: 27413170]

[130]
Pistulli R, Andreas E, König S, et al. Characterization of dendritic cells in human and experimental myocarditis. ESC Heart Fail  2020; 7(5): 2305-17.
 [http://dx.doi.org/10.1002/ehf2.12767] [PMID: 32619089]

[131]
Velázquez-Arellano A, Hernández-Esquivel ML, Sánchez RM, et al. Functional and metabolic implications of biotin deficiency for the rat heart. Mol Genet Metab  2008; 95(4): 213-9.
 [http://dx.doi.org/10.1016/j.ymgme.2008.08.002] [PMID: 18824381]

[132]
Huo Y, Li J, Qin X, et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: The CSPPT randomized clinical trial. JAMA  2015; 313(13): 1325-35.
 [http://dx.doi.org/10.1001/jama.2015.2274] [PMID: 25771069]

[133]
Tu YR, Tu KH, Lee CC, et al. Supplementation with folic acid and cardiovascular outcomes in end-stage kidney disease: A multi-institution cohort study. Nutrients  2022; 14(19): 4162.
 [http://dx.doi.org/10.3390/nu14194162] [PMID: 36235814]

[134]
Huang K, Wu Y, Zhang Y, Youn JY, Cai H. Combination of folic acid with nifedipine is completely effective in attenuating aortic aneurysm formation as a novel oral medication. Redox Biol  2022; 58: 102521.
 [http://dx.doi.org/10.1016/j.redox.2022.102521] [PMID: 36459715]

[135]
Lian Z, Wu Z, Gu R, et al. Evaluation of cardiovascular toxicity of folic acid and 6S-5-Methyltetrahydrofolate-Calcium in early embryonic development. Cells  2022; 11(24): 3946.
 [http://dx.doi.org/10.3390/cells11243946] [PMID: 36552710]

[136]
Webber DM, Li M, MacLeod SL, et al. Gene–folic acid interactions and risk of conotruncal heart defects: Results from the national birth defects prevention study. Genes  2023; 14(1): 180.
 [http://dx.doi.org/10.3390/genes14010180] [PMID: 36672920]

[137]
Yan MX, Zhao Y, Zhao DD, et al. The association of folic acid, iron nutrition during pregnancy and congenital heart disease in northwestern China: A matched case-control study. Nutrients  2022; 14(21): 4541.
 [http://dx.doi.org/10.3390/nu14214541] [PMID: 36364804]

[138]
Jacques PF, Bostom AG, Wilson PWF, Rich S, Rosenberg IH, Selhub J. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr  2001; 73(3): 613-21.
 [http://dx.doi.org/10.1093/ajcn/73.3.613] [PMID: 11237940]

[139]
Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA  1993; 270(22): 2693-8.
 [http://dx.doi.org/10.1001/jama.1993.03510220049033] [PMID: 8133587]

[140]
De Luca M, Valvano A, Striano P, et al. Effects of three-months folate supplementation on early vascular abnormalities in hyperhomocysteinemic patients with epilepsy. Seizure  2022; 103: 120-5.
 [http://dx.doi.org/10.1016/j.seizure.2022.11.009] [PMID: 36402110]

[141]
Savic-Hartwig M, Kerlikowsky F, van de Flierdt E, Hahn A, Schuchardt JP. A micronutrient supplement modulates homocysteine levels regardless of vitamin B biostatus in elderly subjects. Int J Vitam Nutr Res  2023; 0300-9831/a000777.
 [http://dx.doi.org/10.1024/0300-9831/a000777] [PMID: 36715360]

[142]
Wang X, Li W, Xiang M. Increased serum methylmalonic acid levels were associated with the presence of cardiovascular diseases. Front Cardiovasc Med  2022; 9: 966543.
 [http://dx.doi.org/10.3389/fcvm.2022.966543] [PMID: 36299874]

[143]
Dhar I, Lysne V, Ulvik A, et al. Plasma methylmalonic acid predicts risk of acute myocardial infarction and mortality in patients with coronary heart disease: A prospective 2‐cohort study. J Intern Med  2023; 293(4): 508-19.
 [http://dx.doi.org/10.1111/joim.13610] [PMID: 36682040]

[144]
Fu L, Wang Y, Hu YQ. Causal effects of B vitamins and homocysteine on obesity and musculoskeletal diseases: A Mendelian randomization study. Front Nutr  2022; 9: 1048122.
 [http://dx.doi.org/10.3389/fnut.2022.1048122] [PMID: 36505230]

[145]
Fu L, Li Y, Luo D, Deng S, Hu YQ. Plausible relationship between homocysteine and obesity risk viaMTHFR gene: A meta-analysis of 38,317 individuals implementing Mendelian randomization. Diabetes Metab Syndr Obes  2019; 12: 1201-12.
 [http://dx.doi.org/10.2147/DMSO.S205379] [PMID: 31413611]

[146]
Collaboration HLT. Lowering blood homocysteine with folic acid based supplements: Meta-analysis of randomised trials. BMJ  1998; 316(7135): 894-8.
 [http://dx.doi.org/10.1136/bmj.316.7135.894] [PMID: 9569395]

[147]
Manolis AS, Manolis TA, Poulidakis E, Melita H. Beware of the ailments of vitamin B12 deficiency. Hosp Chron  2013; 8(2): 51-7.

[148]
Lawlor DA, Smith GD, Bruckdorfer KR, Kundu D, Ebrahim S. Those confounded vitamins: What can we learn from the differences between observational versus randomised trial evidence? Lancet  2004; 363(9422): 1724-7.
 [http://dx.doi.org/10.1016/S0140-6736(04)16260-0] [PMID: 15158637]

[149]
Mangione CM, Barry MJ, Nicholson WK, et al. Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer. JAMA  2022; 327(23): 2326-33.
 [http://dx.doi.org/10.1001/jama.2022.8970] [PMID: 35727271]
Rights & Permissions Print Cite
Article Metrics
48
3
Journal Information
For Authors
For Editors
For Reviewers
Explore Articles
Open Access
Open Access Articles
For Visitors
DOI https://dx.doi.org/10.2174/1570161121666230912155548	Print ISSN 1570-1611
Publisher Name Bentham Science Publisher	Online ISSN 1875-6212
Current Vascular Pharmacology

Role of Vitamins in Cardiovascular Health: Know Your Facts - Part 1

Abstract

Graphical Abstract

TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE

Current Vascular Pharmacology

Role of Vitamins in Cardiovascular Health: Know Your Facts - Part 1

Abstract

Graphical Abstract

Call for Papers in Thematic Issues

TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE

Related Journals

Related Books

Related Articles
